Purchases and Sales Made in Q4 2022 in Enanta Pharmaceuticals Inc (ENTA)
This table provides information about the institutional ownership of Enanta Pharmaceuticals Inc (ENTA) during Q4 2022. The information is specifically focused on institutions that hold shares of ENANTA PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 09, 2023
Q4 2022
|
Yousif Capital Management, LLC
|
SELL
|
- |
-3.4K- 22.68% |
$139K - $183K
|
11.6K
$108K
|
|
|
Feb 09, 2023
Q4 2022
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-5.12K- 4.01% |
$209K - $275K
|
122K
$1.14M
|
|
|
Feb 06, 2023
Q4 2022
|
Banque Pictet & Cie Sa
|
SELL
|
- |
-5.32K- 23.99% |
$217K - $286K
|
16.9K
$157K
|
|
|
Feb 14, 2023
Q4 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-5.5K- 13.64% |
$224K - $295K
|
34.8K
$325K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-5.81K- 94.55% |
$237K - $312K
|
335
$3.13K
|
|
|
Feb 15, 2023
Q4 2022
|
Public Employees Retirement System Of Ohio
Columbus, OH |
SELL
|
- |
-5.87K- 18.5% |
$239K - $315K
|
25.9K
$242K
|
|
|
Feb 13, 2023
Q4 2022
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-7.03K- 29.9% |
$287K - $378K
|
16.5K
$154K
|
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-9.1K- 12.91% |
$371K - $489K
|
61.4K
$573K
|
|
|
Feb 14, 2023
Q4 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-11.3K- 32.57% |
$461K - $607K
|
23.4K
$219K
|
|
|
Feb 09, 2023
Q4 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-13.2K- 76.23% |
$539K - $710K
|
4.12K
$38.5K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-14.5K- 63.09% |
$592K - $780K
|
8.49K
$79.3K
|
|
|
Feb 13, 2023
Q4 2022
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-20.1K- 56.9% |
$818K - $1.08M
|
15.2K
$142K
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-21.6K- 30.82% |
$882K - $1.16M
|
48.6K
$454K
|
|
|
Feb 14, 2023
Q4 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-28.6K- 56.07% |
$1.17M - $1.54M
|
22.4K
$209K
|
|
|
Jan 12, 2023
Q4 2022
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-39K- 55.45% |
$1.59M - $2.1M
|
31.3K
$293K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-43.1K- 23.75% |
$1.76M - $2.32M
|
139K
$1.29M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-66.4K- 27.58% |
$2.71M - $3.57M
|
174K
$1.63M
|
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-81.3K- 8.43% |
$3.31M - $4.37M
|
883K
$8.25M
|
|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-250K- 70.07% |
$10.2M - $13.4M
|
107K
$996K
|